The current role of the heavy/light chain assay in the diagnosis, prognosis and monitoring of multiple myeloma: an evidence-based approach
R Ríos-Tamayo, N Puig, M Algarín… - Diagnostics, 2021 - mdpi.com
Despite tremendous progress being made in recent years, multiple myeloma (MM) remains
a challenging disease. The laboratory plays a critical role in the overall management of …
a challenging disease. The laboratory plays a critical role in the overall management of …
Risk stratification in multiple myeloma
There are many prognostic variables in multiple myeloma and the difficulty is in deciding
which is truly significant. The widely used International Staging System (ISS) does not …
which is truly significant. The widely used International Staging System (ISS) does not …
Heavy+ light chain monitoring correlates with clinical outcome in multiple myeloma patients
M Michallet, C Chapuis-Cellier, T Dejoie, C Lombard… - Leukemia, 2018 - nature.com
Novel anti-myeloma agents have improved patient response rates, which are historically
based on reductions of the M-protein. These methods can be inaccurate for quantifying M …
based on reductions of the M-protein. These methods can be inaccurate for quantifying M …
Heavy/light chain assay in the monitoring of multiple myeloma
HY Ting, P Sthaneshwar, PC Bee, H Shanmugam… - Pathology, 2019 - Elsevier
Serum protein (SPE) and immunofixation electrophoresis (IFE) have been extensively
validated for the routine use of identifying, characterising and quantifying monoclonal …
validated for the routine use of identifying, characterising and quantifying monoclonal …
[HTML][HTML] A novel approach for more precise quantification of M-protein using variables derived from immunosubtraction electropherogram and associated biochemistry …
Sažetak IntroductionDue to limitations in currently used methodologies, the widely
acknowledged approach for quantifying M-protein (MP) is not available. If employed as a …
acknowledged approach for quantifying M-protein (MP) is not available. If employed as a …
[HTML][HTML] 血清IgD 定量检测在IgD 型多发性骨髓瘤患者疗效评估中的价值
贺婕， 张慧， 姜华， 曾添美， 常洪… - Chinese Journal of …, 2016 - ncbi.nlm.nih.gov
血清IgD定量检测在IgD型多发性骨髓瘤患者疗效评估中的价值- PMC Back to Top Skip to main
content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main …
content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main …
Quantification of β-region IgA monoclonal proteins – should we include immunochemical Hevylite® measurements? Point
JAR Evans, EL Jenner, HD Carr Smith… - Clinical Chemistry and …, 2016 - degruyter.com
Accurate measurement of IgA monoclonal proteins presents a significant challenge to
laboratory staff. IgA heavy/light chain (Hevylite, HLC) analysis is an alternative methodology …
laboratory staff. IgA heavy/light chain (Hevylite, HLC) analysis is an alternative methodology …
[HTML][HTML] 重轻链检测在多发性骨髓瘤疗效评价中的意义
于晓晨， 苏薇， 庄俊玲 - Chinese Journal of Hematology, 2018 - ncbi.nlm.nih.gov
重轻链检测在多发性骨髓瘤疗效评价中的意义- PMC Back to Top Skip to main content NIH
NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation …
NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation …
[PDF][PDF] Verification study of free light chains assays on reagent-optimized analysers
Original articles Page 1 https://doi.org/10.11613/BM.2019.030709 Biochem Med (Zagreb)
2019;29(3):030709 1 Abstract Introduction:Our aim was to compare analytical specifications of …
2019;29(3):030709 1 Abstract Introduction:Our aim was to compare analytical specifications of …
Detection of the value of consecutive serum total light chain (sTLC) in patients diagnosed with diffuse large B cell lymphoma
L Zhai, Y Zhao, S Peng, K Zhu, R Yu, H Chen, T Lin… - Annals of …, 2016 - Springer
There are limited data on serum total light chain (sTLC) in lymphoma and its relative role on
the outcome of diffuse large B cell lymphoma (DLBCL) patients. Blood samples from 46 …
the outcome of diffuse large B cell lymphoma (DLBCL) patients. Blood samples from 46 …